Mashiat Zaman
Calgary, AB T2N4N1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Drug repurposing screen identifies an HRI activating compound that promotes adaptive mitochondrial remodeling in MFN2-deficient cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 25, 2025
Drug Repurposing Screen Identifies an HRI Activating Compound that Promotes Adaptive Mitochondrial Remodeling in MFN2-deficient Cells.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation.
Journal: Life science alliance
Published: July 02, 2024
Pharmacologic Activation of Integrated Stress Response Kinases Inhibits Pathologic Mitochondrial Fragmentation.
Journal: bioRxiv : the preprint server for biology
Published: June 25, 2024
Valosin-Containing Protein (VCP): A Review of Its Diverse Molecular Functions and Clinical Phenotypes.
Journal: International journal of molecular sciences
Published: March 19, 2024
Characterization of a novel variant in the HR1 domain of MFN2 in a patient with ataxia, optic atrophy and sensorineural hearing loss.
Journal: F1000Research
Published: August 22, 2022
The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology.
Journal: Frontiers in cell and developmental biology
Published: January 19, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026